Masugi Maruyama Selected Research

Masugi Maruyama Research Topics

Disease

4	Wounds and Injuries (Trauma) 04/2021 - 01/2012
3	Hemorrhage 11/2017 - 11/2002
2	Inflammation (Inflammations) 02/2022 - 11/2018
2	Insulin Resistance 03/2018 - 01/2013
2	Neoplasms (Cancer) 09/2010 - 02/2009
2	Neoplasm Metastasis (Metastasis) 09/2010 - 02/2009
2	Snake Bites (Snake Bite) 08/2003 - 01/2002
1	Body Weight (Weight, Body) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Cardiotoxicity 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2020
1	Poisoning 11/2020
1	Hemolysis 10/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2019
1	Tuberculosis (Tuberculoses) 12/2018
1	Lipodystrophy 03/2018
1	Obesity 03/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Nausea 01/2018
1	Diarrhea 01/2018
1	Vomiting 01/2018
1	Osteoarthritis 11/2017
1	Skin Neoplasms (Skin Cancer) 02/2017
1	Bone Resorption 04/2016
1	Relative Energy Deficiency in Sport 03/2016
1	Ulcer 09/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Diabetes Mellitus 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 09/2010
1	Hypoxia (Hypoxemia) 02/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2007
1	Adenocarcinoma 01/2005
1	Ischemia 09/2002

Drug/Important Bio-Agent (IBA)

6	ArsenicIBA 11/2020 - 02/2017
3	Drinking WaterIBA 04/2019 - 02/2017
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 01/2013
2	Hemoglobins (Hemoglobin)IBA 11/2017 - 07/2005
2	alloinIBA 04/2016 - 03/2016
2	Oxidants (Oxidizing Agents)IBA 01/2013 - 01/2013
2	Plasminogen Activators (Plasminogen Activator)IBA 09/2010 - 09/2002
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2010 - 09/2002
2	Messenger RNA (mRNA)IBA 01/2005 - 09/2002
2	Plasminogen Activator Inhibitor 1IBA 01/2005 - 09/2002
1	Caspase 1 (ICE Protease)IBA 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	PolymersIBA 04/2021
1	CaspasesIBA 11/2020
1	ElectrolytesIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	MetalsIBA 10/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2020
1	AntigensIBA 12/2018
1	VaccinesIBA 12/2018
1	NF-kappa B (NF-kB)IBA 11/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2018
1	Testosterone (Sustanon)FDA Link 11/2018
1	LipidsIBA 03/2018
1	Aggrecans (Aggrecan)IBA 11/2017
1	CalciumIBA 03/2016
1	MicroRNAs (MicroRNA)IBA 09/2014
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	Uronic AcidsIBA 01/2012
1	Methenamine (Hexamine)IBA 01/2012
1	Proline (L-Proline)FDA Link 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Hydroxyl RadicalIBA 01/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	proanthocyanidinIBA 09/2010
1	AndrogensIBA 09/2010
1	Grape Seed ExtractIBA 09/2010
1	Thymidine PhosphorylaseIBA 02/2009
1	ThymineIBA 02/2009
1	EnzymesIBA 02/2009
1	ThymidineIBA 02/2009
1	IsoflavonesIBA 01/2007
1	GenisteinIBA 01/2007
1	biochanin AIBA 01/2007
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2007
1	Matrix Metalloproteinases (MMPs)IBA 07/2005
1	IronIBA 01/2005
1	Plasminogen InactivatorsIBA 01/2005
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2005
1	PlasminogenIBA 01/2005
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2005
1	VenomsIBA 08/2003
1	murinoglobulinIBA 08/2003
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2003
1	Fibrinogen (Factor I)FDA Link 11/2002
1	jararafibrase IIBA 01/2002
1	Bothrops jararaca VenomIBA 01/2002
1	hemorrhagic metalloproteinaseIBA 01/2002

Therapy/Procedure

1	Intraperitoneal Injections 01/2022
1	Therapeutics 09/2014
1	Drug Therapy (Chemotherapy) 02/2009